The fragmentation reactions of a number of a2 ions ([M−H−CO2]-) derived from dipeptides have been studied
by energy-resolved mass spectrometry, isotopic labeling, and MS3 experiments. The general reaction sequence
leading eventually to a deprotonated amine, is shown to occur, a reaction sequence first proposed by Styles
and O'Hair (Rapid Commun. Mass Spectrom. 1998, 12, 809) from a study of the a2 ion derived from
glycylglycine. When an amidic hydrogen (R2 = H) is present, the initial proton-transfer reaction 1 is
nonreversible. However, when there is no amidic hydrogen, as in the a2 ions derived from H−Ala−Pro−OH
or H−Gly−Sar−OH, the initial proton-transfer reaction 1 becomes reversible, leading to the interchange of
N-bonded and C-bonded hydrogens. Ab initio calculations at the MP2/6-31+G(d) level of the energies and
interconversion pathways of anions derived by deprotonation of glycine N-methylamide show a barrier of 8
kcal mol-1 for reaction 1, with reaction 2 being 23.8 kcal mol-1 endothermic. When an amidic hydrogen (R2
= H) is present, the amine-deprotonated species formed in reaction 1 abstracts a proton from the amide
nitrogen to form the amide-deprotonated species, the most stable species on the potential energy surface. The
system effectively becomes trapped in this low-energy well and exits upon activation by reactions 2 and 3 as
observed when glycine N-methylamide is deprotonated directly. When no amidic hydrogen is present, this
low-energy state does not exist, and reaction 1 becomes reversible, leading to the interchange of N-bonded
and C-bonded hydrogens. In these cases, a significant population of the original a2 ion is formed, which
fragments by the reaction
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.